免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

TEST, 免疫,细胞介导,结核分枝杆菌

PMA编号:P010033 · 2026-01-23

申请人Qiagen
决定日期2026-01-23
PMA 编号P010033
产品代码NCD
设备分类第3类
医疗专科U
咨询委员会抱歉,您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。

器械摘要

TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS is the device name listed in this FDA 510(k) record. The listed applicant is Qiagen. It received FDA 510(k) clearance on 2026-01-23. The device is classified under product code NCD. It was reviewed by the MI advisory panel.

常见问题

What is the TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS?

TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS is a medical device that received FDA 510(k) clearance on 2026-01-23. The listed applicant is Qiagen.

When did TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS receive FDA 510(k) clearance?

The clearance date for TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS can be found in the official FDA records.

TEST、IMMUNITY、CELL MEDIATED、MYCOBACTERIUM TUBERCULOSIS的列名申请人是谁?

The FDA 510(k) record lists Qiagen as the applicant. This does not by itself establish the device manufacturer.

TEST、IMMUNITY、CELL MEDIATED、MYCOBACTERIUM TUBERCULOSIS 的 FDA 产品代码是什么?

FDA产品代码为TEST、IMMUNITY、CELL MEDIATED、MYCOBACTERIUM TUBERCULOSIS的TEST产品是NCD。

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑